Logo
S

Spyryx Biosciences

50 employees

Spyryx Biosciences develops a next-generation therapeutics for obstructive lung diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Pulmonary
Respiratory Therapeutics
Health Diagnostics
Cystic Fibrosis
Genetics
Health Care
Rare and Orphan Diseases

Date founded

2013

Funding rounds raised

Total raised

$18M

from 2 investors over 2 rounds

S

Spyryx Biosciences raised $18M on May 7, 2015

Investors: 5AM Ventures and Canaan

FAQ